0001209191-20-002061.txt : 20200106
0001209191-20-002061.hdr.sgml : 20200106
20200106175706
ACCESSION NUMBER: 0001209191-20-002061
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200102
FILED AS OF DATE: 20200106
DATE AS OF CHANGE: 20200106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MARLETT CHRISTOPHER A
CENTRAL INDEX KEY: 0000897744
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38327
FILM NUMBER: 20511374
MAIL ADDRESS:
STREET 1: 100 WILSHIRE BLVD
CITY: SANTA MONICA
STATE: CA
ZIP: 90401
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cue Biopharma, Inc.
CENTRAL INDEX KEY: 0001645460
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473324577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21 ERIE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-949-2680
MAIL ADDRESS:
STREET 1: 21 ERIE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Imagen Biopharma, Inc.
DATE OF NAME CHANGE: 20150617
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-01-02
0
0001645460
Cue Biopharma, Inc.
CUE
0000897744
MARLETT CHRISTOPHER A
2425 CEDAR SPRINGS ROAD
DALLAS
TX
75201
1
0
0
0
Stock Option (right to buy)
16.31
2020-01-02
4
A
0
8000
0.00
A
2021-01-02
2030-01-02
Common Stock
8000
8000
D
Represents a stock option award granted on January 2, 2020 pursuant to the Issuer's Director Compensation Policy.
/s/ Christopher Marlett by Mark Busch, attorney-in-fact
2020-01-06